College of Medicine and Public Health

Permanent URI for this community

https://hdl.handle.net/2328/26052

The College of Medicine and Public Health deliver clinical, population and lab based research, integrated teaching programs and high quality clinical services.

Our teaching footprint reaches out from our world class teaching hospital at the Flinders Medical Centre in South Australia to multiple rural clinical locations all the way to Darwin in the Northern Territory.

We promote research in health services, systems improvements, public and population health, improved clinical care and laboratory and precision medicine.

This approach has seen us investigate everything from community health problems to the smallest of molecules that influence human disease.

Our research and teaching equips the next generation of leaders and innovators with the skill, commitment and vision to protect vulnerable communities and truly advance health outcomes. It’s at the heart of everything we do.

It’s about improving the health and wellbeing for everyone in society.

Browse

Browsing College of Medicine and Public Health by Subject "1114 Paediatrics and Reproductive Medicine"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial
    (2008) Leach, Amanda Jane; Matthews, John D; Morris, Peter Stanley
    Background : For children at high risk of chronic suppurative otitis media (CSOM), strategies to prevent acute otitis media with perforation (AOMwiP) may reduce progression to CSOM. Methods : In a double blind study in northern Australia, 103 Aboriginal infants with first detection of OME were randomised to receive either amoxicillin (50 mg/kg/d BD) or placebo for 24 weeks, or until bilateral aerated middle ears were diagnosed at two successive monthly examinations (success). Standardised clinical assessments and international standards for microbiology were used. Results : Five of 52 infants in the amoxicillin group and none of 51 infants in the placebo group achieved success at the end of therapy (Risk Difference = 9.6% [95% confidence interval 1.6,17.6]). Amoxicillin significantly reduced the proportion of children with i) perforation at the end of therapy (27% to 12% RD = -16% [-31,-1]), ii) recurrent perforation during therapy (18% to 4% RD = -14% [-25,-2]), and iii) reduced the proportion of examinations with a diagnosis of perforation during therapy (20% to 8% adjusted risk ratio 0.36 [0.15,0.83] p = 0.017). During therapy, the proportion of examinations with penicillin non-susceptible (MIC > 0.1 microg/ml) pneumococci was not significantly different between the amoxicillin group (34%) and the placebo group (40%). Beta-lactamase positive non-capsular H. influenzae (NCHi) were uncommon during therapy but more frequent in the amoxicillin group (10%) than placebo (5%). Conclusion : Aboriginal infants receiving continuous amoxicillin had more normal ears, fewer perforations, and less pneumococcal carriage. There was no statistically significant increase in resistant pneumococci or NCHi in amoxicillin children compared to placebo children who received regular paediatric care and antibiotic treatment for symptomatic illnesses.
  • Thumbnail Image
    Item
    Depression: an important comorbidity with metabolic syndrome in a general population
    (2008) Davis-Lameloise, Nathalie; Philpot, Benjamin Joel; Laatikainen, Tiina K M; Bunker, Stephen; Best, James D; Vartiainen, Erkki; Lo, Sing Kai; Janus, Edward Denis; Dunbar, James Anthony; Reddy, Prasuna; Kilkkinen, Annamari
  • Thumbnail Image
    Item
    Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey
    (2005) Morris, Peter Stanley; Leach, Amanda Jane; Silberberg, Peter; Mellon, Gabrielle; Wilson, Cate; Hamilton, Elizabeth; Beissbarth, Jemima
    Background Middle ear disease (otitis media) is common and frequently severe in Australian Aboriginal children. There have not been any recent large-scale surveys using clear definitions and a standardised middle ear assessment. The aim of the study was to determine the prevalence of middle ear disease (otitis media) in a high-risk population of young Aboriginal children from remote communities in Northern and Central Australia. Methods 709 Aboriginal children aged 6–30 months living in 29 communities from 4 health regions participated in the study between May and November 2001. Otitis media (OM) and perforation of the tympanic membrane (TM) were diagnosed by tympanometry, pneumatic otoscopy, and video-otoscopy. We used otoscopic criteria (bulging TM or recent perforation) to diagnose acute otitis media. Results 914 children were eligible to participate in the study and 709 were assessed (78%). Otitis media affected nearly all children (91%, 95%CI 88, 94). Overall prevalence estimates adjusted for clustering by community were: 10% (95%CI 8, 12) for unilateral otitis media with effusion (OME); 31% (95%CI 27, 34) for bilateral OME; 26% (95%CI 23, 30) for acute otitis media without perforation (AOM/woP); 7% (95%CI 4, 9) for AOM with perforation (AOM/wiP); 2% (95%CI 1, 3) for dry perforation; and 15% (95%CI 11, 19) for chronic suppurative otitis media (CSOM). The perforation prevalence ranged from 0–60% between communities and from 19–33% between regions. Perforations of the tympanic membrane affected 40% of children in their first 18 months of life. These were not always persistent. Conclusion Overall, 1 in every 2 children examined had otoscopic signs consistent with suppurative ear disease and 1 in 4 children had a perforated tympanic membrane. Some of the children with intact tympanic membranes had experienced a perforation that healed before the survey. In this high-risk population, high rates of tympanic perforation were associated with high rates of bulging of the tympanic membrane.